April 28–29, 2026
Kerry Hotel Pudong, Shanghai, China| Digital Partnering May 6–7. 2026 Wheeseong LeeCEO/Founder at Lmito TherapeuticsPresenter
Profile
Lmito develops a novel therapy for autoimmune disorders through a modulation of immunometabolism including a macrophage polarization. In the fibrotic context, LMT compounds exert the anti-fibrotic effects through metabolic reprogramming of profibrotic cells in PF-ILD and IPF.
Agenda Sessions
Autoimmune/Inflammation: Lmito Therapeutics
, 15:30View Session